Abnormal activation of epidermal growth factor receptor (EGFR) is common in different types of cancer including ESCC, which can upregulates the expression of PD-L1 through STAT3 signaling pathway (34, 37). The gene discussed is CD274; the disease is esophageal squamous cell carcinoma.